000			01393 a2200409 4500
005			20250515210509.0
264		0	_c20100525
008			201005s 0 0 eng d
022			_a1875-9114
024	7		_a10.1592/phco.30.3.323 _2doi
040			_aNLM _beng _cNLM
100	1		_aMount, Joshua C
245	0	0	_aUse of methylene blue for refractory septic shock during continuous venovenous hemodiafiltration. _h[electronic resource]
260			_bPharmacotherapy _cMar 2010
300			_a323 p. _bdigital
500			_aPublication Type: Case Reports; Journal Article
650	0	4	_aAccidents, Traffic
650	0	4	_aAcute Kidney Injury _xetiology
650	0	4	_aBlood Pressure _xdrug effects
650	0	4	_aCatecholamines
650	0	4	_aContraindications
650	0	4	_aDrug Resistance
650	0	4	_aFatal Outcome
650	0	4	_aHemodiafiltration
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMethylene Blue _xtherapeutic use
650	0	4	_aMiddle Aged
650	0	4	_aNitric Oxide _xantagonists & inhibitors
650	0	4	_aRenal Replacement Therapy
650	0	4	_aSepsis _xcomplications
650	0	4	_aShock, Septic _xcomplications
650	0	4	_aVasoconstrictor Agents _xtherapeutic use
700	1		_aRowe, A Shaun
773	0		_tPharmacotherapy _gvol. 30 _gno. 3 _gp. 323
856	4	0	_uhttps://doi.org/10.1592/phco.30.3.323 _zAvailable from publisher's website
999			_c19549315 _d19549315